Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Philippe Guilloux

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Molecular Pharmacology|September 25, 2007
Substance P neurokinin 1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortexBruno P Guiard, Jean-Philippe Guilloux, Christelle Reperant, et al.
Fundamental & Clinical Pharmacology|March 10, 2009
Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a reviewAlain M Gardier, Bruno P Guiard, Jean-Philippe Guilloux, et al.
Frontiers in Behavioral Neuroscience|May 14, 2014
Learning and memory impairments in a neuroendocrine mouse model of anxiety/depressionFlavie Darcet, Indira Mendez-David, Laurent Tritschler, et al.
Expert Review of Clinical Pharmacology|August 29, 2014
Vortioxetine for the treatment of major depressive disorderLaurent Tritschler, Daniela Felice, Romain Colle, et al.
European Journal of Pharmacology|December 1, 2009
A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strainDaniela Popa, Julie Cerdan, Christelle Repérant, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2014
Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depressionJean-Philippe Guilloux, Sabrina Bassi, Ying Ding, et al.
Frontiers in Pharmacology|August 4, 2017
S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent MechanismsIndira Mendez-David, Jean-Philippe Guilloux, Mariusz Papp, et al.
Frontiers in Pharmacology|March 30, 2018
Vortioxetine Improves Context Discrimination in Mice Through a Neurogenesis Independent MechanismDaniela Felice, Jean-Philippe Guilloux, Alan Pehrson, et al.
The International Journal of Neuropsychopharmacology|April 9, 2011
Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxietyQuentin Rainer, Lin Xia, Jean-Philippe Guilloux, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 3, 2006
Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout miceJean-Philippe Guilloux, Denis J P David, Bruno P Guiard, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Molecular Pharmacology|September 25, 2007
Substance P neurokinin 1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortexBruno P Guiard, Jean-Philippe Guilloux, Christelle Reperant, et al.
Fundamental & Clinical Pharmacology|March 10, 2009
Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a reviewAlain M Gardier, Bruno P Guiard, Jean-Philippe Guilloux, et al.
Frontiers in Behavioral Neuroscience|May 14, 2014
Learning and memory impairments in a neuroendocrine mouse model of anxiety/depressionFlavie Darcet, Indira Mendez-David, Laurent Tritschler, et al.
Expert Review of Clinical Pharmacology|August 29, 2014
Vortioxetine for the treatment of major depressive disorderLaurent Tritschler, Daniela Felice, Romain Colle, et al.
European Journal of Pharmacology|December 1, 2009
A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strainDaniela Popa, Julie Cerdan, Christelle Repérant, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2014
Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depressionJean-Philippe Guilloux, Sabrina Bassi, Ying Ding, et al.
Frontiers in Pharmacology|August 4, 2017
S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent MechanismsIndira Mendez-David, Jean-Philippe Guilloux, Mariusz Papp, et al.
Frontiers in Pharmacology|March 30, 2018
Vortioxetine Improves Context Discrimination in Mice Through a Neurogenesis Independent MechanismDaniela Felice, Jean-Philippe Guilloux, Alan Pehrson, et al.
The International Journal of Neuropsychopharmacology|April 9, 2011
Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxietyQuentin Rainer, Lin Xia, Jean-Philippe Guilloux, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 3, 2006
Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout miceJean-Philippe Guilloux, Denis J P David, Bruno P Guiard, et al.
Pageof 4